Medicenna Therapeutics Corp.Medicenna Therapeutics Corp.Medicenna Therapeutics Corp.

Medicenna Therapeutics Corp.

No trades
See on Supercharts

Price target

2.900.000.00%
The 3 analysts offering 1 year price forecasts for MDNAF have a max estimate of — and a min estimate of —.

Analyst rating

Based on 3 analysts giving stock ratings to MDNAF in the past 3 months.

EPS

‪0.00‬
Reported
Estimate
Reported
Estimate
Surprise

Revenue

‪0.00‬
Reported
Estimate
Reported
Estimate
Surprise
Be warned

Frequently Asked Questions


MDNAF EPS for the last quarter is −0.04 USD despite the estimation of −0.03 USD. In the next quarter EPS is expected to reach −0.04 USD. Track more of Medicenna Therapeutics Corp. financials and stay on top of what is up with the company.
In the next quarter Medicenna Therapeutics Corp. revenue is expected to reach 0.00 USD. Check out Medicenna Therapeutics Corp. revenue and earnings and make informed decisions.
According to analysts, MDNAF price target is 2.90 USD with a max estimate of 3.63 USD and a min estimate of 1.82 USD. Check if this forecast comes true in a year, meanwhile watch Medicenna Therapeutics Corp. stock price chart and keep track of the current situation with MDNAF news and stock market news.